Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up

Overview of attention for article published in Annals of Hematology, May 2008

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 27 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Combination therapy for the treatment of multiple myeloma

Application US-8765720-B2

United States Patent and Trademark Office